Buy or sell 4D Molecular Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

4D Molecular Therapeutics Stock

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

About 4D Molecular Therapeutics Stock

4D Molecular Therapeutics, we are unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.

Funding History

August 2015$7.0M
September 2017$3.0M



David Schaffer


Anthony Davies

Co-Founder, President & CEO

David Kirn


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from 4D Molecular Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: